Loading...

BDX BECTON DICKINSON & CO Business Restructuring 8-K Filing

BCTN

BDX

BECTON DICKINSON & CO

(BDX)

2025 8-K

Show Summary

Show Summary

Amendments to By-Laws

Financial Statements

Board Appointment

Business Separation

Annual Meeting Results

Management Change

Q4 Financial Results

Hernia Litigation Settlement

Leadership Change

Financial Results Announcement

Notes Offerings

Financial Results Announcement

Departure of Directors

Underwriting Agreements for...

Financial Results Announcement

Annual Meeting Voting Results

Settlement Agreement in Cla...

Departure of Directors or C...

Financial Results Announcement

Amendments to By-laws

Financial Results Announcement

Public Offering

Financial Results Announcement

Entry into Material Definit...

Material Definitive Agreeme...

Underwriting Agreements

Financial Results Announcement

Amendments to Compensation ...

Quantitative Data

Departure of Directors

External Links:

Becton Dickinson announced its financial results for the first fiscal quarter ending December 31, 2024, and plans to separate its Biosciences and Diagnostic Solutions business, targeting completion by fiscal 2026.

AI Assistant

BECTON DICKINSON & CO

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.